Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio.
about
Recent Advances in Tumor Ablation for Hepatocellular CarcinomaDiagnostic and therapeutic management of hepatocellular carcinomaDefect Reperfusion Imaging with Sonazoid®: A Breakthrough in Hepatocellular CarcinomaProspective study of differential diagnosis of hepatic tumors by pattern-based classification of contrast-enhanced sonography.Can contrast-enhanced ultrasonography characterize focal liver lesions and differentiate between benign and malignant, thus providing a one-stop imaging service for patients?()Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonographyDifferentiation of focal liver lesions using three-dimensional ultrasonography: retrospective and prospective studiesCharacterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma.Differentiation between malignant and benign nodules in the liver: use of contrast C3-MODE technology.Evaluation of contrast-enhanced ultrasound for diagnosis of dysplastic nodules with a focus of hepatocellular carcinoma in liver cirrhosis patientsEarly detection and characterization of hepatocellular carcinoma: value of imaging multistep human hepatocarcinogenesis.Surveillance and diagnosis for hepatocellular carcinoma.Clinical management of focal liver lesions: the key role of real-time contrast-enhanced US.Multistep human hepatocarcinogenesis: correlation of imaging with pathology.Diagnostic imaging of hepatocellular carcinoma: recent progress.Changes of guidelines diagnosing hepatocellular carcinoma during the last ten-year period.Effect of observer experience in the differentiation between benign and malignant liver tumors after ultrasound contrast agent injection.Hepatic malignancies: Correlation between sonographic findings and pathological features.Diagnostic value of contrast-enhanced ultrasound in hepatocellular carcinoma: a meta-analysis with evidence from 1998 to 2016.Terminology for contrast-enhanced sonography: a practical glossary.New malignant grading system for hepatocellular carcinoma using the Sonazoid contrast agent for ultrasonography.Contrast-enhanced US of ampullary carcinoma: correlations with pathological findings.Diagnostic accuracy of contrast-enhanced ultrasound in differentiating benign and malignant focal liver lesions: a retrospective study.Differential diagnosis of nodular lesions in cirrhotic liver by post-vascular phase contrast-enhanced US with Levovist: comparison with superparamagnetic iron oxide magnetic resonance images.Usefulness of early vascular phase images from contrast-enhanced ultrasonography using Sonazoid for the diagnosis of hypovascular hepatocellular carcinoma.Contrast-enhanced 3D ultrasonography in minute hepatocellular carcinoma.Uterine myomas treated with microwave ablation: the agreement between ablation volumes obtained from contrast-enhanced sonography and enhanced MRI.Recent advances in the diagnosis of hepatocellular carcinomaPreliminary study of contrast-enhanced harmonic endosonography with second-generation contrast agents
P2860
Q26775418-437DA29C-9C07-4911-A9A8-5B43997A8553Q26999043-39F7B806-06E8-4DE5-9C68-7E0B098ED96BQ30388235-F7B59855-72A2-4F95-B103-48B5B53ADF3EQ30433373-B6768102-3322-4E88-9ABA-0C435B934D3AQ30458384-756FBDA3-AC67-4DD4-8D92-B38C589AF907Q30479629-CD5C6F46-CA70-4951-9008-DFAE39FE738AQ30542675-70151063-366A-412D-98BE-839E82F636B7Q33830708-8CBD2984-4FDB-497B-9187-97647FF1818DQ34558527-054FABA4-CD39-4D50-B0BC-27F881823211Q35010173-586CBCD0-1B4E-4D42-AD73-912103E06D0CQ35085490-FC9489E4-8F78-4F5C-A743-2A31C3E600FDQ36258730-4DDAF979-8731-405E-9100-C47AE53C5E18Q36985216-3E274B34-6C8B-4D5C-B81E-D66918B39BA4Q37123161-73245D99-5D6E-461F-A62A-0A8E295BC790Q37370018-AB56BDDE-959C-486B-B9F3-F58C8B6EB04BQ37972809-B104FA18-736E-49A9-B6B0-3A30AF0F6BA1Q38054740-0B046AB6-DC60-4588-A2E1-D3FE029B4195Q39913302-CC35B223-DE76-4D1D-B2FC-0F6BE6ECF21EQ41126839-C5BC85DA-76D4-4813-9F6E-B46602BD34B2Q43171014-61C2CCA5-2BF8-4F15-B075-0EDFB7021CADQ44021980-F8A8DD36-A296-4920-8056-05A697A113D2Q45364465-90F642BA-748F-4906-88BB-9FAAF341D990Q50514137-8290B2FD-A6FB-4CE7-9D50-94E00BDE6C95Q51646217-AFEFBCD5-6031-4E0E-96B6-48002D63EC39Q53558298-DE66487F-651F-4193-83F7-DBC72E16E44EQ53674461-377BDA91-8F12-491D-B5E1-C94C0D027877Q54079238-AE58112E-0EC9-451A-B2BA-57D9D16D744CQ54522222-C98BA0C7-13B7-453F-9D08-487A7F30D1AAQ56994598-E5F8681E-DAE8-46D2-8A0D-0206D2AA8A6DQ57763602-D3A06493-7735-4AF6-B376-E64F3BF3BC40
P2860
Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Characterization of hepatic tu ...... hase-inversion harmonic angio.
@en
Characterization of hepatic tu ...... hase-inversion harmonic angio.
@nl
type
label
Characterization of hepatic tu ...... hase-inversion harmonic angio.
@en
Characterization of hepatic tu ...... hase-inversion harmonic angio.
@nl
prefLabel
Characterization of hepatic tu ...... hase-inversion harmonic angio.
@en
Characterization of hepatic tu ...... hase-inversion harmonic angio.
@nl
P2093
P1476
Characterization of hepatic tu ...... hase-inversion harmonic angio.
@en
P2093
Hobyung Chung
Kiyoshi Maekawa
Masayuki Kitano
Rong Qin Zheng
Toshihiko Kawasaki
Yan Ling Wen
Yasunori Minami
P304
P356
10.2214/AJR.182.4.1821019
P407
P577
2004-04-01T00:00:00Z